Please contact us for more information or to learn if you are eligible to participate.
The primary goal of this study is to gather efficacy data concerning overall survival with electromagnetic fields when compared to a placebo amplitude-modulated radiofrequency electromagnetic field device in subjects who have failed or are intolerant to at least two previous systemic therapies.
Dr. Lee C. Drinkard
Edgar Lopez Pacheco
Wake Forest Baptist Comprehensive Cancer Center
Type of Trial